Newly discovered signalling pathways important for future brain cancer therapy
Each year, more than 1 300 people in Sweden are diagnosed with brain cancer. An international collaboration with researchers from the University of Wales, the United States and IGP have now uncovered molecular targets that might lead to a new generation of brain cancer therapies. The results are published today in a paper in the journal Cancer Discovery.
Glioblastoma is a lethal form of brain tumour with a poor prognosis as they are resistant to therapy and infiltrate structures in the healthy brain.
“The aggressive behaviours that we see in glioblastomas can be attributed to cancer stem cells, which are a small population of cells in a tumour that divide to drive tumour growth and are responsible for the spread of the cancer around the body. If we can understand the activities of cancer stem cells we can target these particular cells, which we believe will enable us to develop a more effective therapy,” says Florian Siebzehnrubl at Cardiff University, who has led the study.
The researchers wanted to determine which signals allow cancer stem cells in the brain continue to give rise to new cancer cells and why they are resistant to current cancer therapies. The identified molecules, called ADAMDEC1 and FGFR1, are proteins that are given off from cancer stem cells to communicate with other cells around them. The proteins help keep the cancer stem cells healthy so that they can continue to divide and grow the tumour.
“When we blocked the genes for ADAMDEC1 and FGFR1, or by inhibiting the activity of the two proteins, we found that the glioblastoma stem cells were killed off and the tumour growth slowed down. This makes these proteins possible therapeutic targets for glioblastoma, and through further research we can investigate their effectiveness as therapeutic targets,” says Florian Siebzehnrubl.
The results indicate new signalling pathways for the regulation of cancer stem cells, by which this cell population can selectively access key nutrients in their surrounding environment. It is also an example of how cancer stem cells can engage in communication with their microenvironment to ensure their growth.
Glioblastoma is a disease that differs widely between different patients, which makes it very difficult to treat. Researchers in Uppsala have established a biobank of cells from glioblastoma patients, that has been used it this project. The new study has laid the foundations to potentially uncovering a new class of brain cancer therapies, which will hopefully make a difference to the treatment of this lethal disease in the future.
“This project illustrates the importance of combining studies of biobanks material with cultured cells from many patients. This can allow us to uncover new mechanisms of cancer vulnerabilities that may be turned into personalised therapies,” says Karin Forsberg Nilsson at IGP, who has participated in the study from Uppsala University.
Paper in Cancer Discovery
Karin Forsberg Nilsson’s research
Disrupted immune cell navigation in lymph nodes of breast cancer patients
Different types of breast cancer tumours differ in how they affect the function of the lymph nodes. In patients with invasive breast cancer, the vessels and supporting tissue of the lymph nodes are altered, which cannot be seen in patients with a non-invasive cancer called (ductal cancer in situ). This is shown in a new study from Maria Ulvmar’s group at IGP, published online in the scientific journal Cancers.
Oral contraceptive pills protect against ovarian and endometrial cancer
A comprehensive study from Uppsala University, involving more than 250,000 women, shows that oral contraceptive use protects against ovarian and endometrial cancer. The protective effect remains for several decades after discontinuing the use. The study is published in the journal Cancer Research.
Vener bakom blodkärlsmissbildningar i hjärnan
In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers in Elisabetta Dejana's group at IGP can now show, at molecular level, that these changes originate in vein cells. This new knowledge of the condition creates potential for developing better therapies for patients. The study has been published in the journal eLife.
World’s largest ever DNA sequencing of Vikings
Genetic examinations of more than 400 Viking age skeletons reveal that the Vikings that raided Europe came from relatively isolated groups in Scandinavia and many of them had a genetic influx from Asia or Southern Europe. This is presented in a study in the journal Nature, in which Marie Allen and Magdalena Bus from IGP have participated.
Internet-based support can reduce depressions symptoms in cancer patients
The internet can be used to provide education and support for self-management interventions to alleviate depression symptoms in individuals with cancer. This is shown in a study from Birgitta Johansson’s group at IGP.
Leakage from blood and lymphatic vessels is differently regulated
Researchers from IGP show in a new study that cell signalling regulating vessel leakage differs between blood and lymphatic vessels. The findings suggest a possibility to modulate this signalling in order to selectively control lymphatic vessel function and to treat diseases characterised by lymphatic vessel leakage.
New early biomarker for several cancer diseases
In a study including more than 400 hospital patients with 18 different cancer diagnoses, researchers have been able to show that EVP, extracellular vesicles and particles, could be used as biomarkers for several cancer diseases. The study has been led by researchers from among others IGP.
New findings on enzymes with important role in SARS-CoV-2 infection
Researchers at IGP have described the presence, throughout the human body, of the enzyme ACE2. This is thought to be the key protein used by the SARS-CoV-2 virus for host cell entry and development of the disease COVID-19. In contrast to previous studies, the study shows that no or very little ACE2 protein is present in the normal respiratory system. The results are presented in Molecular Systems Biology.
Unexpected associations found between drug response and cell changes in brain cancer
Therapies for treating glioblastoma brain cancer can be delivered with greater precision and existing drugs can be used in new ways. These are the conclusions from a study from IGP investigating a large number of cell samples from patients with brain tumours. The researchers have characterised how changes in glioblastoma cells influence the effect of different drugs. Their findings are published in the journal Cell Reports.
New method to identify genes that can drive development of brain tumors
Researchers at Uppsala University have developed a method for identifying functional mutations and how these affect genes with significance for the development of glioblastoma – a malignant brain tumor with very poor prognosis. The study is published in Genome Biology.
New effective way to inhibit lymphatic malformations
Lymphatic malformation is a debilitating and often incurable disease. Taija Mäkinen’s research group has in an international collaboration studied cellular mechanisms leading to abnormal vessel growth and identified a combination therapy that may allow effective treatment of these malformations.
Lymphatic vessels in mice and humans: alike yet different
In an international collaboration, researchers from IGP have mapped the lymph node lymphatic vessels in mice and humans down to the level of individual cells. The results may eventually help scientists to discover new methods for strengthening the immune system against viruses and cancer. Their work has been published in the journal Frontiers of Cardiovascular Research.
Scientists identify cause of leakiness in eye diseases
Targeting a molecule that contributes to leaky eye vessels, while sparing nerve and blood-vessel cells, could be a safer treatment strategy for age and diabetes-related vision loss. Scientists at IGP have identified a key step in the process that leads to leaky vessels and harmful swelling in eye diseases, according to a new study published today in the journal eLife.
Changes in cellular degradation hubs can lead to cancer
Cancer cells grow and divide in an uncontrolled manner. A new study from IGP now shows how alterations in a cell’s degradation hubs, called lysosomes, can cause abnormal cell growth. The results are published today in the scientific journal Nature Communications.
Careless cancer cells may be susceptible to future drugs
Could the ability of cancer cells to quickly alter their genome be used as a weapon against malignant tumours? Researchers at IGP have succeeded in developing a substance that has demonstrated promising results in experiments on both animal models and human cancer cells. The study is published in the journal Nature Communications.
Smart algorithm finds possible future treatment for childhood cancer
Using a computer algorithm, scientists at IGP have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialised nerve cells in the sympathetic nervous system, may be life-threatening. In the long term the discovery, described in the latest issue of the scientific journal Nature Communications, may result in a new form of treatment for children in whom the disease is severe or at an advanced stage.